While cancer cells are typically more glycolytic, and several studies have reported anti-proliferative and anti-invasive effects of glycolysis inhibition through ENO1,93 our experiments inhibiting ENO1 in cell lines and a PDO with collagenous microenvironments show that this targeted only the fraction of the population that is non-invasive. This evidence concerns the gene ENO1 and cancer.